Catalyst Trusteeship Limited has filed a regulatory disclosure regarding the creation of encumbrance on shares of Tanfac Industries Limited under SEBI's substantial acquisition regulations. The disclosure, dated February 18, 2026, pertains to a non-disposal undertaking created on February 14, 2026.

Transaction Details

The encumbrance involves 25,73,081 equity shares of Tanfac Industries, representing 25.80% of the company's total equity share capital. Catalyst Trusteeship Limited is acting as an onshore security agent in this transaction and is not part of the promoter or promoter group of Tanfac Industries.

Holdings Comparison

The disclosure shows Catalyst Trusteeship's holdings before and after the encumbrance creation:

Share Capital Structure

Tanfac Industries currently has 99,75,000 equity shares as per the publicly available shareholding pattern dated December 31, 2025. However, the company's board approved a share split on January 9, 2026, which will increase the total equity shares to 1,99,50,000 upon completion.

Regulatory Compliance

The disclosure was filed with BSE Limited and National Stock Exchange of India Limited, where Tanfac Industries' shares are listed. Deesha Srikkanth, Senior Vice President at Catalyst Trusteeship Limited, signed the disclosure as the authorized signatory from Mumbai.

Corporate Action Impact

The pending share split will effectively double the number of encumbered shares to 51,46,162, while maintaining the same percentage holding of 25.80%. This encumbrance represents a significant stake in Tanfac Industries and demonstrates Catalyst Trusteeship's role as a security agent in what appears to be a structured financing arrangement.

TANFAC Industries Limited has filed its institutional investor presentation with BSE Limited under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation, dated February 12, 2026, provides comprehensive insights into the company's operations, financial performance, and strategic initiatives.

Company Overview and Operations

TANFAC Industries operates as an established fluorine chemical manufacturer with a proven track record since 1985. The company is strategically located in Cuddalore, Tamil Nadu, operating manufacturing facilities spread over 60 acres. As a joint sector company with TIDCO and Anupam Rasayan India Ltd., TANFAC has positioned itself as one of the market leaders in the domestic Hydrofluoric Acid market.

Product Portfolio and Market Position

The company maintains a diversified product portfolio focused on fluorine chemistry, including:

• Anhydrous Hydrofluoric Acid (AHF)
• Solar Grade Diluted Hydrofluoric Acid
• Sulphuric Acid
• Potassium Fluoride (KF) and other fluorine derivatives

TANFAC holds the distinction of being the first and only supplier of Solar Grade Diluted Hydrofluoric Acid in India, demonstrating its technological capabilities and market leadership in specialty chemicals.

Strategic Developments and Partnerships

The company has achieved several significant milestones, including the successful completion of its HF expansion project in October 2024, delivered within projected time and cost parameters. A major strategic achievement includes securing a long-term agreement with Japanese customers for the supply of 7,500 MTPA refrigerant gas over 7 years, valued at approximately Rs. 2,362 crores.

Financial Performance Highlights

The presentation reveals strong financial performance across multiple periods. For FY 2024-25, TANFAC achieved its highest ever revenue and net profit. The company's Q3 FY26 and 9-month FY26 results demonstrate continued growth momentum, with EBITDA calculations excluding other income to provide clearer operational performance metrics.

Research and Development Capabilities

TANFAC operates a fully equipped R&D laboratory at Cuddalore with expertise in various fluorination techniques including vapor phase fluorination, diazotization using AHF, Halex reaction using KF, and side-chain fluorination. The company has successfully developed several products at lab scale and demonstrated capabilities to scale production from laboratory to commercial levels.

Market Outlook and Growth Opportunities

The presentation highlights promising market opportunities in fluorochemicals, with the global fluorochemicals market showing a CAGR of 5.3% and the India market demonstrating stronger growth at 8.1% CAGR. The hydrofluoric acid segment shows even more robust growth potential, with India's AHF market projected to grow at 9.7% CAGR compared to the global rate of 5.3%.

The investor presentation is available on the company's website at www.tanfac.com , providing stakeholders with detailed information about TANFAC's strategic positioning, operational excellence, and growth trajectory in the fluorine chemicals industry.